Navigation Links
Cholesterol byproduct blocks heart health benefits of estrogen
Date:9/16/2007

sdorf, a Howard Hughes Medical Institute investigator at UT Southwestern. This study not only illustrates the damaging effects high cholesterol has on the heart but also supports the notion that the relative levels of 27HC and estrogen in the vasculature are contributing factors to the risk for cardiovascular disease.

In normal premenopausal women, the amount of 27HC generated from cholesterol is relatively low compared to the level of estrogen circulating in the blood, leading to enhanced cardiovascular protection. In contrast, when the level of 27HC is higher relative to estrogen, such as during the postmenopausal period or as a consequence of high cholesterol, the researchers speculate that 27HC out-competes estrogen to bind with estrogen receptors, blocking the function of the receptors and resulting in a loss of protection.

This model may help explain why women are better protected than men from cardiovascular disease until they reach menopause, said Dr. Mangelsdorf.

The findings also may help explain why a large clinical trial that evaluated certain hormone replacement therapies (HRT) in postmenopausal women a component of the 15-year Womens Health Initiative had to be halted in 2002 when the hormones appeared to increase a womans risk of heart disease.

In the Womens Health Initiative research program, the women who began taking HRT were an average of 13 years postmenopause, Dr. Manglesdorf said. By the time they started taking this estrogen again, the damage caused by 27HC binding to the estrogen receptors in the cardiovascular system may already have occurred. Once you lose estrogens protection for such an extended period of time, you cant get it back.

The researchers also found that 27HC works predominantly on estrogen receptors in the cardiovascular system. When it binds to estrogen receptors in other tissues, such as reproductive tissues, it has no effect on their reproduction-related functions. This prope
'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. A better way to measure cholesterol
3. Evening,the best time to take Cholesterol Drug
4. Cholesterol Drugs Prevent Breast Cancer
5. In Search Of A New Drug To Target Cholesterol
6. Testicular cancer linked to high cholesterol
7. Genetics and cholesterol levels
8. Frequent meals can reduce cholesterol
9. Eating More Often May Help Lower Cholesterol
10. Lecithin lowers cholesterol absorption in body
11. Step Aerobics Increases good cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... bill Medicare for consultations how will they get paid for ... to understand terms. , ... Washington, ... Medicare will eliminate consultation codes. These codes are what ... is seen for a medical consultation, whether in a provider’s ...
(Date:12/15/2009)... America,s premier manufacturer of Spa, Massage, and Medical tables announces ... an adjustable breast comfort system to ease pressure felt while ... ... New Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, ... equipment, today announced the launch of the Utopian Massage Table ...
(Date:12/15/2009)... 15 issue of the Journal of Clinical Sleep ... the risk for developing obstructive sleep apnea (OSA) in ... Results indicate that the risk of OSA among Caucasian ... fold with each standard-deviation increase in body mass index ... significantly increase with increasing BMI among younger children. ...
(Date:12/14/2009)... and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... Scientists at UC Santa Barbara, in collaboration with scientists at ... the characteristics and key functions of natural red blood cells, ... , , , , ,The primary function of natural red ...
(Date:12/14/2009)... LOVELAND, Colo., Dec. 14 Heska ... the "Company"), a leading provider of veterinary ... first customer installation of the Company,s new ... 7000"). ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ... the fastest multi-patient clinical chemistry analyzer available ...
Breaking Medicine News(10 mins):Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
... displacement in the ivyleaf morning glory" , Robin ... , How do we know that interactions between ... abundant evidence to suggest that plant-pollinator interactions influence ... direct evidence that interactions between plant species shape ...
... INDIANAPOLIS, Jan. 4 Eli Lilly and Company,(NYSE: LLY ... and,full year of 2007 on Tuesday, January 29, 2008. Lilly ... investment community and media to,further detail the company,s financial performance., ... to 10:00 a.m. EST.,Investors, media and the general public can ...
... HARRISBURG, Pa., Jan. 4 With the cut of ... some 400 jobs in,Northumberland County and mark the acquisition ... PRWT Services Inc. took over the operation of ... Danville, on Jan. 1. The facility will be,known as ...
... as well with more cost-effective conventional film screenings, study ... results from a landmark trial released in 2005 concluded ... cancers than conventional film mammography was. , But a ... of Internal Medicine , concludes that digital mammography is ...
... get serious about ... health, once and for all, NEW ... and stroke are the nation,s No. 1 and No. 3,killers, claiming ... obese., (Photo: http://www.newscom.com/cgi-bin/prnh/20080104/LAF034 ), World-renowned entertainer Donny Osmond ...
... for 29 categories of awards in the 2007 Association ... Best Monthly Professional Society Magazine as well as the ... winners will be honored at the Salute to Association ... 1996, JBS is the official publication of the Society ...
Other Medicine News:Health News:January American Naturalist highlights 2Health News:January American Naturalist highlights 3Health News:January American Naturalist highlights 4Health News:January American Naturalist highlights 5Health News:January American Naturalist highlights 6Health News:January American Naturalist highlights 7Health News:January American Naturalist highlights 8Health News:January American Naturalist highlights 9Health News:January American Naturalist highlights 10Health News:January American Naturalist highlights 11Health News:January American Naturalist highlights 12Health News:January American Naturalist highlights 13Health News:Not All Women Need Digital Mammograms 2Health News:Donny Osmond, American Heart Association Team Up to Get Americans Walking 2
(Date:12/14/2009)... Dec. 14 Cardium Therapeutics (NYSE Amex: ... 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment ... Healing: Science and Industry Conference held December 10-13, ... The conference is attended by top industry leaders ... wound healing. Dr. Barbara K. Sosnowski, Cardium,s ...
(Date:12/14/2009)... SKIPPACK, Pa., Dec. 14 At GeoInvesting.com, we ... ) for some time now. Our largest hang up ... Although the Company,s fiscal June 2010 net income guidance ... fiscal 2009 reported net income of $7.9 million, the ... term EPS growth scenario, which depends upon the share ...
(Date:12/14/2009)... HELSINKI, Dec. 14 Cancer patients in ... with the introduction of RapidArc® radiotherapy technology from ... at the only private radiotherapy clinic in the ... are using this fast and precise form of ... and cancers of the abdomen and prostate. ,, ...
Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Time to Turn the Town Pink 57587 1Time to Turn the Town Pink 57587 2Dey L P Settles State of Utah Pricing Litigation 57583 1Dey L P Settles State of Utah Pricing Litigation 57583 2The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand 57580 1
... - ORENCIA is a First-in-Class Biologic Treatment Option Now Available ... Use in Pediatric Patients with ... Company (NYSE: BMY ) today announced that the U.S. ... signs,and symptoms in pediatric patients six years and older with ...
... Inc. (Nasdaq: ARNA ) announced today that ... of APD125 in patients with primary,insomnia. APD125 is ... the,potential to reduce insomnia symptoms and improve sleep ... APD125 is a double-blind, randomized, placebo-,controlled subjective study ...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5
...
...
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
Medicine Products: